Samidorphan: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Samidorphan. Educational only — not medical advice.
Labeled uses
LYBALVI is indicated for the treatment of: Schizophrenia in adults Bipolar I disorder in adults Acute treatment of manic or mixed episodes as monotherapy and as adjunct to lithium or valproate Maintenance monotherapy treatment
Source: FDA labeling via NIH DailyMed (set 32ffddd1…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.